Your browser doesn't support javascript.
loading
Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer.
Nguyen, Thi Truc Anh; Postlewait, Lauren M; Zhang, Chao; Meisel, Jane L; O'Regan, Ruth; Badve, Sunil; Kalinsky, Kevin; Li, Xiaoxian.
Afiliación
  • Nguyen TTA; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Postlewait LM; Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, GA, USA.
  • Zhang C; Pediatric Biostatistics Core, Department of Pediatrics, Emory University, Atlanta, GA, USA.
  • Meisel JL; Department of Hematology and Oncology, Emory University, Atlanta, GA, USA.
  • O'Regan R; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Badve S; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Kalinsky K; Department of Hematology and Oncology, Emory University, Atlanta, GA, USA.
  • Li X; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA. xli40@emory.edu.
Breast Cancer Res Treat ; 192(3): 509-516, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35084624

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Estrógenos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Estrógenos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos